Fort Lee, NJ -- (ReleaseWire) -- 01/17/2017 --Herborium® Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) targeting dermatological issues such as acne, and other health and wellness concerns is happy to announce that as of Tuesday, January 10, 2017 the Company has achieved OTC Pink Current information status, which implies that the company is providing adequate current information pursuant to the OTC Markets Guidelines for Pink companies.
This development reflects the Company's on-going commitment to create and increase shareholders value while fostering the Company growth and development. The global nutraceutical market was valued at ~ USD 250 billion in 2016 and is expected to reach ~ USD 385 billion by 2021.
Herborium Group's products and expertise in developing and marketing proprietary, all herbal medicinal formulas (Botanical Therapeutics®) with a proven record of efficacy, represents an ideal fit with new, nutraceutical market trends, as well as more demanding manufacturing and regulatory standards for the industry.
About Herborium Group, Inc.
Herborium Group, Inc. is a botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr and www.acneassp.com
Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.
Contact Information:
Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com or DrAgnes@Herborium.com
Source: Uptick Newswire
Herborium Achieves the Current Information Status on OTC Pink